Latest News

Riliprubart Demonstrates Favorable Benefit-Risk Profile as Potential Treatment for Chronic Demyelinating Polyneuropathy
Riliprubart Demonstrates Favorable Benefit-Risk Profile as Potential Treatment for Chronic Demyelinating Polyneuropathy

April 13th 2024

Patients on riliprubart demonstrated improvements on several measures of disability and impairment, including the INCAT, I-RODS, MRC-SS, and grip strength.

Earlier Initiation of Ublituximab Results In Improved Disease Outcomes in Treatment-Naïve Multiple Sclerosis
Earlier Initiation of Ublituximab Results In Improved Disease Outcomes in Treatment-Naïve Multiple Sclerosis

April 13th 2024

Pooled Phase 3 Studies Highlight AXS-07 as Effective Migraine Treatment
Pooled Phase 3 Studies Highlight AXS-07 as Effective Migraine Treatment

April 13th 2024

Study Identifies Factors Preceding Headache Remission in Adolescents
Study Identifies Factors Preceding Headache Remission in Adolescents

April 12th 2024

NeurologyLive® Friday 5 — April 12, 2024
NeurologyLive® Friday 5 — April 12, 2024

April 12th 2024

AAN 2024
MDA 2024
Roundtable Discussions
NeuroVoices
Mind Moments podcast
Sleeping Around the Podcast with Dr. Ann Marie Morse
Gold Standard Centers
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Brain Games

Conference Coverage

View All
Riliprubart Demonstrates Favorable Benefit-Risk Profile as Potential Treatment for Chronic Demyelinating Polyneuropathy
Riliprubart Demonstrates Favorable Benefit-Risk Profile as Potential Treatment for Chronic Demyelinating Polyneuropathy

April 13th 2024

Earlier Initiation of Ublituximab Results In Improved Disease Outcomes in Treatment-Naïve Multiple Sclerosis
Earlier Initiation of Ublituximab Results In Improved Disease Outcomes in Treatment-Naïve Multiple Sclerosis

April 13th 2024

Pooled Phase 3 Studies Highlight AXS-07 as Effective Migraine Treatment
Pooled Phase 3 Studies Highlight AXS-07 as Effective Migraine Treatment

April 13th 2024

Krystyn J. Van Vliet, PhD & Anna Jagielska, PhD, MSc
Bridging Engineering and Neuroscience in the Creation of Artificial Axons for Myelination Research: Krystyn J. Van Vliet, PhD & Anna Jagielska, PhD, MSc

April 11th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.